Standout Papers

Determination of subcutaneous tumor size in athymic (nude) mice 1989 2026 2001 2013 1.5k
  1. Determination of subcutaneous tumor size in athymic (nude) mice (1989)
    Mary M. Tomayko, C. Patrick Reynolds Cancer Chemotherapy and Pharmacology
  2. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid (1999)
    Katherine K. Matthay, Judith G. Villablanca et al. New England Journal of Medicine
  3. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma (2010)
    Alice L. Yu, Andrew L. Gilman et al. New England Journal of Medicine
  4. Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy (2009)
    Min H. Kang, C. Patrick Reynolds Clinical Cancer Research
  5. The two different receptors for tumor necrosis factor mediate distinct cellular responses. (1991)
    Louis A. Tartaglia, R F Weber et al. Proceedings of the National Academy of Sciences
  6. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study (2009)
    Katherine K. Matthay, C. Patrick Reynolds et al. Journal of Clinical Oncology
  7. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma (1985)
    Carol J. Thiele, C. Patrick Reynolds et al. Nature

Immediate Impact

19 by Nobel laureates 25 from Science/Nature 83 standout
Sub-graph 1 of 17

Citing Papers

Stimuli-responsive ferroptosis for cancer therapy
2023 Standout
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
2021 Standout
8 intermediate papers

Works of C. Patrick Reynolds being referenced

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
2016
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
2014
and 8 more

Author Peers

Author Last Decade Papers Cites
C. Patrick Reynolds 12521 9528 4744 4945 336 21.4k
Akira Nakagawara 11163 6809 4293 5178 344 17.6k
John M. Maris 13389 15412 8299 6156 465 26.0k
Nai‐Kong V. Cheung 6648 7493 2943 5436 389 16.3k
Garrett M. Brodeur 14244 15946 6509 5196 242 24.6k
William A. Weiss 9145 3395 3690 2764 267 15.0k
Hideyuki Saya 13997 1478 4333 7097 451 23.3k
Mark W. Kieran 6613 2468 2670 2628 268 14.7k
Frank Baas 9327 3113 951 5357 357 21.4k
P. O’Connell 6614 3788 1995 2297 245 15.3k
Alice L. Yu 6035 3173 1806 2699 293 11.6k

All Works

Loading papers...

Rankless by CCL
2026